The Supreme Court of India issued a show-cause notice to Patanjali Ayurved and its managing director, Acharya Balkrishna, on February 27th, 2024, for violating their promise to stop making misleading claims in their advertisements.
Key points:
The court also restrained Patanjali from advertising any cure claims for diseases listed in the Drugs and Magic Remedies Act, 1954.
The court criticized both Patanjali and the government, stating that the company was "taking the entire country for a ride" and the government was "not taking action."
The Centre was asked to file an affidavit outlining steps taken to prevent companies from misrepresenting medicines in media.
This action follows a writ petition filed by the Indian Medical Association (IMA) against misleading advertisements by Patanjali and other companies.
Patanjali had previously promised to stop making false claims in November 2023, but the court noted they continued the practice.